Alkermes plc (ALKS) financial statements (2020 and earlier)

Company profile

Business Address CONNAUGHT HOUSE
DUBLIN 4, 00000
State of Incorp.
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2013
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments535539434497535631221
Cash and cash equivalents20426719118618122497
Short-term investments331273242311354407124
Receivables257292234191155152125
Inventory, net of allowances, customer advances and progress billings102909363385143
Inventory102909363385143
Contract with customer, asset88
Prepaid expense and other current assets19
Deferred tax assets 0001 
Other undisclosed current assets605348392641 
Total current assets:962983809791755877409
Noncurrent Assets
Operating lease, right-of-use asset12
Property, plant and equipment362310285265255266288
Long-term investments and receivables798115712226417083
Long-term investments798115712226417083
Intangible assets, net (including goodwill)244284349411472574669
Goodwill93939393939493
Intangible assets, net (excluding goodwill)151191256318379479576
Business combination, contingent consideration, asset3265856355 
Other noncurrent assets171614271435
Prepaid expense and other noncurrent assets22
Deferred tax assets, net 1119 
Other undisclosed noncurrent assets9786984740(9) 
Total noncurrent assets:8438429889361,1011,0441,062
TOTAL ASSETS:1,8051,8251,7971,7261,8561,9211,470
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:37333428620716912177
Accounts payable54405646373218
Accrued liabilities937365536350 
Other undisclosed accounts payable and accrued liabilities226221166107693959
Deferred revenue7
Debt113336677
Due to related parties     37 
Deferred revenue and credits22232
Contract with customer, liability3
Other undisclosed current liabilities     (37) 
Total current liabilities:39134029121223613186
Noncurrent Liabilities
Long-term debt and lease obligation280276278281284351362
Long-term debt, excluding current maturities274276278281284351362
Operating lease, liability5
Liabilities, other than long-term debt49372524214572
Deferred revenue and credits678129
Deferred revenue22
Contract with customer, liability10
Asset retirement obligations     22
Deferred tax liabilities, net   01938
Other liabilities27281917131223
Other undisclosed noncurrent liabilities     (2)(2)
Total noncurrent liabilities:329314303305305394432
Total liabilities:720654594517541524518
Stockholders' equity
Stockholders' equity attributable to parent1,0851,1711,2031,2091,3141,397952
Common stock2222211
Treasury stock, value(118)(109)(89)(73)(59)(32)(5)
Additional paid in capital2,5862,4672,3392,2322,1151,9431,459
Accumulated other comprehensive loss(2)(3)(4)(3)(4)(3)(3)
Accumulated deficit(1,382)(1,185)(1,044)(948)(739)(512)(500)
Total stockholders' equity:1,0851,1711,2031,2091,3141,397952
TOTAL LIABILITIES AND EQUITY:1,8051,8251,7971,7261,8561,9211,470

Income statement (P&L) ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2013
Revenues1,1711,094903746628619576
Revenue, net903746628619576
Cost of revenue(180)(176)(155)(132)(142)(216)(170)
Cost of goods and services sold(180)(176)(155)(132)(139)(176)(170)
Gross profit:991918749614486403405
Operating expenses(1,166)(1,017)(897)(822)(710)(490)(323)
Other undisclosed operating income      0
Operating income (loss):(175)(99)(148)(209)(224)(87)82
Nonoperating income (expense)(22)(28)5(6)073(46)
Investment income, nonoperating149541321
Other nonoperating income (expense)1(2)(10)(2)0(2)2
Interest and debt expense(14)(2)(12)(2)(13)(13)(69)
Other undisclosed income from continuing operations before equity method investments, income taxes142122131369
Income (loss) from continuing operations before income taxes:(197)(127)(143)(214)(224)(14)35
Income tax expense (benefit)0(12)(15)6(3)(16)(10)
Net income (loss) available to common stockholders, diluted:(197)(139)(158)(208)(227)(30)25

Comprehensive Income ($ in millions)

12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
12/31/2014
3/31/2013
Net income (loss):(197)(139)(158)(208)(227)(30)25
Other comprehensive loss    (0)(8) 
Comprehensive income (loss):(197)(139)(158)(208)(227)(38)25
Other undisclosed comprehensive income (loss), net of tax, attributable to parent11(1)1(0)(6)0
Comprehensive income (loss), net of tax, attributable to parent:(195)(139)(158)(208)(228)(44)25

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: